MindMaze Therapeutics: Consolidating a Global Approach to Reimbursement for Next-Generation Therapeutics 
Jushi Holdings Inc. Completes Previously Disclosed Amendments to 12% Second Lien Notes and Warrants
BOCA RATON, Fla., June 30, 2023 (GLOBE NEWSWIRE) -- Jushi Holdings Inc. (“Jushi” or the “Company”) (CSE: JUSH) (OTCQX: JUSHF),...
Castellum, Inc. Generates Record Monthly Revenue
Castellum, Inc. Generates Record Monthly Revenue Castellum, Inc. (the “Company”) (NYSE-American: CTM) record $4.25 million in unaudited revenue for May...
Enterome announces first patient dosed in a Phase 1/2 trial with third OncoMimics™ immunotherapy, EO4010, in Metastatic Colorectal Cancer
EO4010 uniquely mimics five distinct tumor-associated antigens designed to provide multi-targeted, broad tumor coverage, maximizing tumor killing and preventing immune...
Immuron Chairman Transition
MELBOURNE, Australia, June 30, 2023 (GLOBE NEWSWIRE) -- Immuron Limited (ASX: IMC; NASDAQ: IMRN), an Australian based and globally integrated...
Samsung Bioepis Releases 2023 Sustainability Report
Highlights key initiatives that will drive the company’s transition towards a more sustainable businessReaffirms commitment to environmentally and socially responsible...
Vistin Pharma ASA: Offer to buy back shares
30 June 2023: Vistin Pharma ASA (the “Company”) has decided to launch an offer to all shareholders in the Company...
Spexis announces engagement with Maxim Group LLC as M&A advisor to support evaluation of strategic transactions
Ad hoc announcement pursuant to Art. 53 LR ALLSCHWIL, Switzerland, June 29, 2023 (GLOBE NEWSWIRE) -- Spexis AG (SIX: SPEX),...
Press release Biocartis Group NV: Disclosure of Outstanding Voting Securities
PRESS RELEASE - REGULATED INFORMATION 30 June 2023, 7:00 CEST Disclosure of Outstanding Voting Securities Mechelen, Belgium, 30 June 2023...
ObsEva SA Announces that Shareholders Approved all Board Proposals at its 2023 Annual General Meeting held on June 29, 2023
Ad hoc announcement pursuant to Art. 53 LR of the SIX Swiss Exchange Geneva, Switzerland – June 30, 2023 –...
BioSenic provides financial update
INSIDE INFORMATION Launch of negotiation with main creditors Agreement with Global Tech Opportunities (GTO) to secure short term financing Mont-Saint-Guibert,...
Ipsen and GENFIT Announce Positive Results from Phase III ELATIVE® trial of elafibranor in patients with primary biliary cholangitis, a rare cholestatic liver disease
Trial met primary endpoint with a statistically significant higher percentage of patients achieving a clinically meaningful cholestasis response compared to...
Ipsen and GENFIT Announce Positive Results from Phase III ELATIVE trial of elafibranor in patients with primary biliary cholangitis, a rare cholestatic liver disease
Trial met primary endpoint with a statistically significant higher percentage of patients achieving a clinically meaningful cholestasis response compared to...
Black Diamond Therapeutics Announces Pricing of Public Offering of Common Stock
CAMBRIDGE, Mass and NEW YORK, June 29, 2023 (GLOBE NEWSWIRE) -- Black Diamond Therapeutics, Inc. (Nasdaq: BDTX), a clinical-stage precision...
PETVIVO HOLDINGS, INC. ANNOUNCES RESCHEDULED EARNINGS CALL FOR THE YEAR ENDED MARCH 31, 2023
MINNEAPOLIS, MN, US, June 29, 2023 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (NASDAQ: PETV and PETVW), an emerging biomedical device...
AVITA Medical Submits FDA PMA Supplement for RECELL GO
VALENCIA, Calif., June 29, 2023 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a regenerative medicine company leading...
FDA Grants De Novo Marketing Authorization for KidneyIntelX.dkd to Assess Risk of Progressive Kidney Function Decline in Adults with Diabetes and Early-Stage Kidney Disease
Simple Blood Test Aids Risk Assessment for Approximately 14 Million Eligible Patients in the United States Diabetic Kidney Disease is the...
Bionano Announces the Stratys™ System for OGM and VIA™ Software for Hematologic Malignancies
The Stratys™ instrument for optical genome mapping (OGM) will enable a four-fold increase in raw data generation rate compared to...
Advanced Health Intelligence Ltd Announces Implementation of ADS Ratio Change
NEW YORK, June 29, 2023 (GLOBE NEWSWIRE) -- Advanced Health Intelligence Ltd (ASX/NASDAQ:AHI) (“Advanced Health Intelligence”, “AHI” or the “Company”)...
VitalHub Corp. Announces Results of Annual General Meeting of Shareholders
TORONTO, June 29, 2023 (GLOBE NEWSWIRE) -- VITALHUB CORP. (TSX: VHI) (OTCQX: VHIBF) (the “Company” or “VitalHub”) today reported a...
Zenocutuzumab (Zeno) granted Breakthrough Therapy Designation by the U.S. Food & Drug Administration for the treatment of NRG1+ pancreatic cancer
UTRECHT, The Netherlands and CAMBRIDGE, Mass., June 29, 2023 (GLOBE NEWSWIRE) -- Merus N.V. (Nasdaq: MRUS), a clinical-stage oncology company...